Acadia Healthcare Company Inc (NASDAQ:ACHC) has been assigned a consensus rating of “Hold” from the fourteen analysts that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation and four have given a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $42.20.
Several research analysts have recently commented on the company. ValuEngine lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Friday. Zacks Investment Research upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and set a $48.00 target price for the company in a research report on Tuesday, July 24th. Credit Suisse Group lifted their target price on Acadia Healthcare from $40.00 to $44.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 31st. BidaskClub lowered Acadia Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, August 1st. Finally, Jefferies Financial Group lifted their target price on Acadia Healthcare from $44.00 to $47.00 and gave the stock a “buy” rating in a research report on Tuesday, July 31st.
In related news, Director Reeve B. Waud sold 41,865 shares of the business’s stock in a transaction that occurred on Thursday, November 1st. The stock was sold at an average price of $45.00, for a total transaction of $1,883,925.00. Following the completion of the transaction, the director now owns 14,213 shares in the company, valued at approximately $639,585. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 11.10% of the company’s stock.
Shares of NASDAQ ACHC opened at $32.55 on Friday. Acadia Healthcare has a fifty-two week low of $28.02 and a fifty-two week high of $45.35. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 1.19. The company has a market cap of $3.18 billion, a price-to-earnings ratio of 14.15, a price-to-earnings-growth ratio of 1.56 and a beta of 0.22.
Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Monday, November 5th. The company reported $0.55 EPS for the quarter, missing the consensus estimate of $0.64 by ($0.09). The firm had revenue of $760.90 million during the quarter, compared to analyst estimates of $760.46 million. Acadia Healthcare had a return on equity of 7.71% and a net margin of 7.43%. Acadia Healthcare’s revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.58 EPS. Equities analysts expect that Acadia Healthcare will post 2.3 earnings per share for the current fiscal year.
About Acadia Healthcare
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.
Recommended Story: Technical Analysis of Stocks, How Can It Help
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.